Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
US Army
Express Scripts
Medtronic
Accenture
Cipla
Citi
Chubb
Cerilliant

Generated: May 24, 2018

DrugPatentWatch Database Preview

OGESTREL 0.5/50-21 Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Ogestrel 0.5/50-21, and when can generic versions of Ogestrel 0.5/50-21 launch?

Ogestrel 0.5/50-21 is a drug marketed by Watson Labs and is included in one NDA.

The generic ingredient in OGESTREL 0.5/50-21 is ethinyl estradiol; norgestrel. There are twenty-six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestrel profile page.
Summary for OGESTREL 0.5/50-21
Drug patent expirations by year for OGESTREL 0.5/50-21

US Patents and Regulatory Information for OGESTREL 0.5/50-21

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs OGESTREL 0.5/50-21 ethinyl estradiol; norgestrel TABLET;ORAL-21 075406-001 Dec 15, 1999 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Chinese Patent Office
Argus Health
Cantor Fitzgerald
Federal Trade Commission
Accenture
Healthtrust
Mallinckrodt
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.